513 related articles for article (PubMed ID: 12115616)
21. Toll and Toll-like proteins: an ancient family of receptors signaling infection.
Imler JL; Hoffmann JA
Rev Immunogenet; 2000; 2(3):294-304. PubMed ID: 11256741
[TBL] [Abstract][Full Text] [Related]
22. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
23. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
[TBL] [Abstract][Full Text] [Related]
24. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
Senn JJ; Burel S; Henry SP
J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
[TBL] [Abstract][Full Text] [Related]
25. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.
Yamada M; Oritani K; Kaisho T; Ishikawa J; Yoshida H; Takahashi I; Kawamoto S; Ishida N; Ujiie H; Masaie H; Botto M; Tomiyama Y; Matsuzawa Y
Eur J Immunol; 2004 Jan; 34(1):221-30. PubMed ID: 14971048
[TBL] [Abstract][Full Text] [Related]
26. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
Underhill DM; Ozinsky A; Hajjar AM; Stevens A; Wilson CB; Bassetti M; Aderem A
Nature; 1999 Oct; 401(6755):811-5. PubMed ID: 10548109
[TBL] [Abstract][Full Text] [Related]
27. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide.
Gao JJ; Diesl V; Wittmann T; Morrison DC; Ryan JL; Vogel SN; Follettie MT
J Leukoc Biol; 2002 Dec; 72(6):1234-45. PubMed ID: 12488506
[TBL] [Abstract][Full Text] [Related]
28. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
29. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
[TBL] [Abstract][Full Text] [Related]
30. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
[TBL] [Abstract][Full Text] [Related]
31. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
[TBL] [Abstract][Full Text] [Related]
32. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.
Honda K; Yanai H; Mizutani T; Negishi H; Shimada N; Suzuki N; Ohba Y; Takaoka A; Yeh WC; Taniguchi T
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15416-21. PubMed ID: 15492225
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
34. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
[TBL] [Abstract][Full Text] [Related]
35. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
36. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88.
von Loewenich FD; Scorpio DG; Reischl U; Dumler JS; Bogdan C
Eur J Immunol; 2004 Jul; 34(7):1789-97. PubMed ID: 15214027
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.
Lund J; Sato A; Akira S; Medzhitov R; Iwasaki A
J Exp Med; 2003 Aug; 198(3):513-20. PubMed ID: 12900525
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus.
Abe T; Hemmi H; Miyamoto H; Moriishi K; Tamura S; Takaku H; Akira S; Matsuura Y
J Virol; 2005 Mar; 79(5):2847-58. PubMed ID: 15709004
[TBL] [Abstract][Full Text] [Related]
39. TIRAP: how Toll receptors fraternize.
Henneke P; Golenbock DT
Nat Immunol; 2001 Sep; 2(9):828-30. PubMed ID: 11526396
[No Abstract] [Full Text] [Related]
40. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
